Literature DB >> 8527449

Stoichiometry of p22-phox and gp91-phox in phagocyte cytochrome b558.

J Huang1, N D Hitt, M E Kleinberg.   

Abstract

The phagocyte NADPH oxidase complex is an unusual electron transfer system. Its principal component, cytochrome b558, is a heme-containing integral membrane protein consisting of two subunits, gp91-phox and p22-phox. We used a novel method to measure precisely the gp91-phox:p22-phox stoichiometry. Cytochrome b558 was isolated in high purity from human neutrophil membrane preparations using a novel affinity purification method. We performed direct peptide sequencing of purified cytochrome b558 and detected two amino acid sequences which matched predicted sequences for gp91-phox and p22-phox. We quantitated amounts of both amino acids released from p22-phox and gp91-phox in each sequencing cycle. Averaging over 25 cycles, the mean p22-phox:gp91-phox ratio of released amino acids was 0.93 +/- 0.01. To correct for recovery differences between individual amino acids, we measured individual p22-phox:gp91-phox ratios for the eight different amino acids common to both p22-phox and gp91-phox in the first 25 positions. The mean of individual p22-phox:gp91-phox ratios for the eight common amino acids was 0.96 +/- 0.05. The p22-phox:gp91-phox ratios for each of the eight common amino acids varied from 0.81 to 1.20. Taken together, measured ratios for total and individual amino acids are consistent with a predicted ratio of 1.0 for 1:1 p22-phox:gp91-phox stoichiometry in cytochrome b558.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8527449     DOI: 10.1021/bi00051a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

Review 1.  Chronic granulomatous disease.

Authors:  D Goldblatt; A J Thrasher
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

2.  Stoichiometry of the subunits of flavocytochrome b558 of the NADPH oxidase of phagocytes.

Authors:  T M Wallach; A W Segal
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

Review 3.  NADPH oxidases: an overview from structure to innate immunity-associated pathologies.

Authors:  Arvind Panday; Malaya K Sahoo; Diana Osorio; Sanjay Batra
Journal:  Cell Mol Immunol       Date:  2014-09-29       Impact factor: 11.530

Review 4.  Regulation of reactive oxygen species generation in cell signaling.

Authors:  Yun Soo Bae; Hyunjin Oh; Sue Goo Rhee; Young Do Yoo
Journal:  Mol Cells       Date:  2011-12-22       Impact factor: 5.034

Review 5.  The molecular basis of chronic granulomatous disease.

Authors:  C Meischl; D Roos
Journal:  Springer Semin Immunopathol       Date:  1998

Review 6.  The NADPH oxidase of professional phagocytes--prototype of the NOX electron transport chain systems.

Authors:  Andrew R Cross; Anthony W Segal
Journal:  Biochim Biophys Acta       Date:  2004-06-28

7.  Gp91(phox) is the heme binding subunit of the superoxide-generating NADPH oxidase.

Authors:  L Yu; M T Quinn; A R Cross; M C Dinauer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

8.  The Emerging Roles of Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 in Skeletal Muscle Redox Signaling and Metabolism.

Authors:  Carlos Henríquez-Olguín; Susanna Boronat; Claudio Cabello-Verrugio; Enrique Jaimovich; Elena Hidalgo; Thomas E Jensen
Journal:  Antioxid Redox Signal       Date:  2019-11-01       Impact factor: 8.401

Review 9.  Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors.

Authors:  Michael J Surace; Michelle L Block
Journal:  Cell Mol Life Sci       Date:  2012-05-13       Impact factor: 9.261

10.  Properties of phagocyte NADPH oxidase p47-phox mutants with unmasked SH3 (Src homology 3) domains: full reconstitution of oxidase activity in a semi-recombinant cell-free system lacking arachidonic acid.

Authors:  Guihong Peng; Jin Huang; Mellonie Boyd; Michael E Kleinberg
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.